Y.S.P. Southeast Asia Holding Berhad (YSPSAH) Stock Overview
Engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
YSPSAH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.
Read full narrativeY.S.P. Southeast Asia Holding Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 2.12 |
| 52 Week High | RM 2.33 |
| 52 Week Low | RM 2.02 |
| Beta | 0.027 |
| 1 Month Change | 3.41% |
| 3 Month Change | 1.44% |
| 1 Year Change | -3.64% |
| 3 Year Change | -13.47% |
| 5 Year Change | -3.64% |
| Change since IPO | 18.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| YSPSAH | MY Pharmaceuticals | MY Market | |
|---|---|---|---|
| 7D | 1.4% | 1.3% | 1.3% |
| 1Y | -3.6% | 2.3% | 11.7% |
Return vs Industry: YSPSAH underperformed the MY Pharmaceuticals industry which returned 2.3% over the past year.
Return vs Market: YSPSAH underperformed the MY Market which returned 11.7% over the past year.
Price Volatility
| YSPSAH volatility | |
|---|---|
| YSPSAH Average Weekly Movement | 1.7% |
| Pharmaceuticals Industry Average Movement | 4.2% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in MY Market | 11.9% |
| 10% least volatile stocks in MY Market | 2.8% |
Stable Share Price: YSPSAH has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: YSPSAH's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 1,361 | Fang-Hsin Lee | www.yspsah.com |
Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices.
Y.S.P. Southeast Asia Holding Berhad Fundamentals Summary
| YSPSAH fundamental statistics | |
|---|---|
| Market cap | RM 300.71m |
| Earnings (TTM) | RM 25.03m |
| Revenue (TTM) | RM 365.12m |
Is YSPSAH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YSPSAH income statement (TTM) | |
|---|---|
| Revenue | RM 365.12m |
| Cost of Revenue | RM 204.03m |
| Gross Profit | RM 161.08m |
| Other Expenses | RM 136.05m |
| Earnings | RM 25.03m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.18 |
| Gross Margin | 44.12% |
| Net Profit Margin | 6.86% |
| Debt/Equity Ratio | 7.5% |
How did YSPSAH perform over the long term?
See historical performance and comparisonDividends
Does YSPSAH pay a reliable dividends?
See YSPSAH dividend history and benchmarks| Y.S.P. Southeast Asia Holding Berhad dividend dates | |
|---|---|
| Ex Dividend Date | Jun 26 2026 |
| Dividend Pay Date | Jul 20 2026 |
| Days until Ex dividend | 45 days |
| Days until Dividend pay date | 69 days |
Does YSPSAH pay a reliable dividends?
See YSPSAH dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/11 23:22 |
| End of Day Share Price | 2026/05/11 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Y.S.P. Southeast Asia Holding Berhad is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yi Jing Chua | Affin Hwang Investment Bank |
| Lik Hsin Aw | CGS International |
| Bei Shan Ng | MBSB Research |